Eureka Therapeutics, Inc.

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

• MCMichael CannonDirector
• VCVivien ChanExecutive Officer
• SCSandy ChauDirector
• "C"Wai-Yan ""Sandy""" ChauDirector
• CCChih-Kai ChengDirector
• "C"Chih-Kai ""C.K." ChengDirector
• "C"Chih-Kai ""C.K.""" ChengDirector
• BFBo FengDirector
• QFQiushi FuDirector
• RJReed JobsDirector
• HKHsing KungDirector
• CLChristopher LehmanExecutive Officer
• CLCheng LiuDirector · Executive Officer
• BNBijan NejadnikExecutive Officer
• JNJacqueline NorthcutDirector
• MSMarvin SamsonDirector
• VSVictor ShumExecutive Officer
• WSWiliam Solari IIIDirector
• WSWilliam Solari IIIDirector
• LWLewis WilliamsDirector

• 16 Jun 2026Antibodies Targeting G-protein Coupled Receptor And Methods Of Usegranted
• 26 May 2026Antibodies Targeting Fc Receptor-like 5 And Methods Of Usegranted
• 05 May 2026Humanized Antibodies To MUCIN-16 And Methods Of Use Thereofgranted
• 27 Nov 2025Antibody/t-cell Receptor Chimeric Constructs And Uses Thereofapplication
• 27 Nov 2025Antibodies To MUCIN-16 And Methods Of Use Thereofapplication
• 25 Nov 2025Constructs Specifically Recognizing Glypican 3 And Uses Thereofgranted
• 11 Sept 2025Compositions Targeting GPC2 And GPC3 And Their Use For Treating Solid Tumorsapplication
• 20 Feb 2025Chimeric Antigen Receptors Targeting Fc Receptor-like 5 And Uses Thereofapplication
• 09 Jan 2025Constructs Targeting Prostate-specific Membrane Antigen (psma) And Uses Thereofapplication
• 17 Dec 2024Antibodies To MUCIN-16 (MUC16), Encoding Polynucleotides And Methods Of Treating MUC16-POSITIVE Cancergranted
• 12 Nov 2024Chimeric Antigen Receptors Targeting Fc Receptor-like 5 And Uses Thereofgranted
• 10 Oct 2024Methods Of Using Chimeric Antigen Receptors Targeting B-cell Maturation Antigen And Uses Thereofapplication

• 07 Jul 2026New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
• 30 Jun 2026Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
• 30 Jun 2026Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
• 29 Jun 2026Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
• 26 Jun 2026Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
• 26 Jun 2026Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.